China vs Mali: Previously treated cases tested for RR-/MDR-TB
China
92.0%
in 2024
Mali
93.0%
in 2024
China rank
79th
Mali rank
78th
Previously treated cases tested for RR-/MDR-TB over time
- China
- Mali
How they compare
Mali currently reports 93.0% against 92.0% in China, a difference of 1.0%.
The two have swapped places 6 times across 14 shared years of data; in 2007 it was Mali ahead.
China ranks 79th and Mali ranks 78th of 180 countries.
Across the 3 decades both report, China averaged higher in 2 and Mali in 1.
Head to head by decade
| Decade | China | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2% | 1.4% | 1.2% | Mali |
| 2010s | 62.0% | 27.4% | 34.6% | China |
| 2020s | 92.2% | 74.6% | 17.6% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, China or Mali?
- Mali, at 93.0% against 92.0% in China as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between China and Mali?
- 1.0%, with Mali ahead.
- How many years of comparable data are there for China and Mali?
- 14 years are reported by both, from 2007 to 2024.
- How do China and Mali rank globally for previously treated cases tested for rr-/mdr-tb?
- China ranks 79th and Mali ranks 78th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.